Carisma Therapeutics, Inc.CARMNASDAQ
Loading
Revenue ScalingExpanding
Percentile Rank100
3Y CAGR+74.9%
5Y CAGR+36.2%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+74.9%/yr
Annual compound
5Y CAGR
+36.2%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
4.7x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$52.63M+168.1%
2024$19.63M+31.6%
2023$14.92M+51.7%
2022$9.83M-63.0%
2021$26.54M+136.2%
2020$11.24M-
2019$0.00-
2018$0.00-100.0%
2017$425000.00-98.6%
2016$29.98M-